1. Self-Reported Questionnaire Detects Family History of Cancer in a Pancreatic Cancer Screening Program. Lucas AL, Tarlecki A, Van Beck K, Lipton C, RoyChoudhury A, Levinson E, Kumar S, Chung WK, Frucht H, Genkinger JM. Journal of genetic counseling. 2016; PubMed [journal]PMID: 28039657

2. Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017. Lucas AL, Malvezzi M, Carioli G, Negri E, La Vecchia C, Boffetta P, Bosetti C. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2016; 14(10):1452-1462.e4. NIHMSID: NIHMS793076 PubMed [journal]PMID: 27266982 PMCID: PMC5028258

3. The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer. Amin S, Boffetta P, Lucas AL. Gut and liver. 2016; 10(5):665-71. PubMed [journal]PMID: 27563018 PMCID: PMC5003188

4. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis. Amin S, Mhango G, Lin J, Aronson A, Wisnivesky J, Boffetta P, Lucas AL. The American journal of gastroenterology. 2016; 111(9):1350-7. NIHMSID: NIHMS815864 PubMed [journal]PMID: 27430290 PMCID: PMC5041138

5. Dietary total antioxidant capacity and pancreatic cancer risk: an Italian case-control study. Lucas AL, Bosetti C, Boffetta P, Negri E, Tavani A, Serafini M, Polesel J, Serraino D, La Vecchia C, Rossi M. British journal of cancer. 2016; 115(1):102-7.
PubMed [journal]PMID: 27172251 PMCID: PMC4931362

6. Adherence to World Cancer Research Fund/American Institute for Cancer Research recommendations and pancreatic cancer risk. Lucas AL, Bravi F, Boffetta P, Polesel J, Serraino D, La Vecchia C, Bosetti C.Cancer epidemiology. 2016; 40:15-21.
PubMed [journal]PMID: 26605429

7. MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions. Hernandez YG, Lucas AL. World journal of gastrointestinal oncology. 2016; 8(1):18-29. PubMed [journal]PMID: 26798434 PMCID: PMC4714143

8. Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer. Hassid BG, Lucas AL, Salomao M, Weng C, Liu F, Khanna LG, Kumar S, Hwang C, Chabot JA, Frucht H. Pancreas. 2014; 43(7):1073-7. NIHMSID: NIHMS599120 PubMed [journal]PMID: 24987871 PMCID: PMC4161626

9. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. Becker AE, Hernandez YG, Frucht H, Lucas AL. World journal of gastroenterology. 2014; 20(32):11182-98. PubMed [journal]PMID: 25170203 PMCID: PMC4145757

10. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts. Lucas AL, Frado LE, Hwang C, Kumar S, Khanna LG, Levinson EJ, Chabot JA, Chung WK, Frucht H. Cancer. 2014; 120(13):1960-7. PubMed [journal]PMID: 24737347

11. Molecular tumor testing for Lynch syndrome in patients with colorectal cancer. Matloff J, Lucas A, Polydorides AD, Itzkowitz SH. Journal of the National Comprehensive Cancer Network : JNCCN. 2013; 11(11):1380-5. PubMed [journal]PMID: 24225971

12. High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions. Lucas AL, Shakya R, Lipsyc MD, Mitchel EB, Kumar S, Hwang C, Deng L, Devoe C, Chabot JA, Szabolcs M, Ludwig T, Chung WK, Frucht H. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013; 19(13):3396-403. NIHMSID: NIHMS516037 PubMed [journal]PMID: 23658460 PMCID: PMC3959126

13. Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis. Amin S, Lucas AL, Frucht H. Pancreas. 2013; 42(2):249-53. NIHMSID: NIHMS516046 PubMed [journal]PMID: 22836862 PMCID: PMC3958965

14. The prevention and genetics of pancreatic cancer: a programmatic approach. Lucas AL, Chang MM, Lipsyc MD, Frucht H. Methods in molecular biology (Clifton, N.J.). 2013; 980:205-14. NIHMSID: NIHMS516047 PubMed [journal]PMID: 23359155 PMCID: PMC3959119

15. Incidence of subsequent pancreatic adenocarcinoma in patients with a history of nonpancreatic primary cancers. Amin S, McBride RB, Kline JK, Mitchel EB, Lucas AL, Neugut AI, Frucht H. Cancer. 2012; 118(5):1244-51. NIHMSID: NIHMS468850 PubMed [journal]PMID: 21887676 PMCID: PMC3677019

16.  Strengthening the case for stool DNA tests as first-line colorectal cancer screening: are we there yet? Lucas AL, Hwang C, Frucht H. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2012; 10(3):214-5. PubMed [journal]PMID: 22138275

17. Screening and detection of pancreatic cancer. Highlights from the “2011 ASCO Annual Meeting”. Chicago, IL, USA; June 3-7, 2011. Gonda TA, Lucas A, Saif MW. JOP : Journal of the pancreas. 2011; 12(4):322-4. NIHMSID: NIHMS572925
PubMed [journal]PMID: 21737887 PMCID: PMC4034356

18. A foreign body larger than the overtube diameter: a case of a large cow foot bone causing esophageal impaction. Swaminath A, Lucas AL, Capiak K, Sethi A, Garcia-Carrasquillo R. Gastroenterology & hepatology. 2010; 6(12):793-5.
PubMed [journal]PMID: 21301633 PMCID: PMC3033554

19. The case for early chemotherapy for the treatment of metastatic disease. Lucas A, Petrylak DP. The Journal of urology. 2006; 176(6 Pt 2):S72-5. PubMed [journal]PMID: 17084173